Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 173
Filter
Add more filters











Publication year range
1.
Bull Exp Biol Med ; 168(1): 52-54, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31741247

ABSTRACT

We studied the effect of gonadotropin-releasing hormone agonist surfagon (2 µg/kg, once, intraperitoneally) on anxious behavior of adult gonadectomized and non-gonadectomized male rats. It was shown that surfagon significantly increased anxiety of both gonadectomized and non-gonadectomized rats in the open-field test and in elevated plus maze.


Subject(s)
Gonadotropin-Releasing Hormone/analogs & derivatives , Animals , Anxiety/metabolism , Behavior, Animal/drug effects , Follicle Stimulating Hormone/metabolism , Gonadotropin-Releasing Hormone/metabolism , Gonadotropin-Releasing Hormone/pharmacology , Luteinizing Hormone/metabolism , Male , Rats , Testosterone/metabolism
2.
Patol Fiziol Eksp Ter ; 60(1): 36-43, 2016.
Article in Russian | MEDLINE | ID: mdl-29215244

ABSTRACT

Methods: Experiments were carried out on outbred albino male rats (n = 150, 230-250 g). For modeling dislipoproteinemia (DLP) we used 3 models: single intraperitoneal injection of the detergent triton WR-1339; administration of ethanol; maintenance on a special hypercholesterolaemic diet (HD) during 21 days. Animals were divided into four groups: normal control, model group, gemfibrozil (Gfb) group, benzohexonium (Benz) group. Rats received per os benzohexonium (20mg/kg), reference drug gemfibrozil (50 mg/kg). We determined content of total cholesterol (TCh), triglycerides (TG) in samples of blood serum and liver, TCh in aorta. TCh, TG and Ch-HDL were analyzed spectrophotometrically using of standardized methods. Results: Compared with model group the contents of TCh, TG in serum and liver were significantly decreased in model + Benz group, whereas Ch-HDL was raised in rats fed special HD (P<0.05). Calculated index of atherogenity (TCh - Ch-HDL) / (Ch-HDL) showed the positive effect. Conclusion: The results obtained were shown the hypolipidemic activity of N-cholinergic antagonist Benzohexonium (20 mg/kg) lowered the content of lipids in blood, liver, and aorta.


Subject(s)
Cholinergic Agonists , Dyslipidemias , Hexamethonium Compounds , Hypolipidemic Agents , Animals , Cholinergic Agonists/pharmacokinetics , Cholinergic Agonists/pharmacology , Dyslipidemias/blood , Dyslipidemias/drug therapy , Hexamethonium Compounds/pharmacokinetics , Hexamethonium Compounds/pharmacology , Hypolipidemic Agents/pharmacokinetics , Hypolipidemic Agents/pharmacology , Male , Rats
3.
Bull Exp Biol Med ; 160(2): 228-30, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26639469

ABSTRACT

The antiarrhythmic effect of taurepar, an N-phenylalkyl derivative of taurine, was examined in experiments on rats subjected to acute myocardial ischemia/reperfusion leading to arrhythmia development. During acute ischemia, taurepar (25 mg/kg) completely prevented early postocclusion arrhythmias including extrasystoles, ventricular tachycardia, and ventricular fibrillation. During postischemic reperfusion, taurepar (25 mg/kg) did not prevent extrasystoles and ventricular tachycardia, but precluded the development of ventricular fibrillation and the death of animals. The antiarrhythmic potency of taurepar surpassed that of lidocaine during acute myocardial ischemia and that of propranolol during ischemia/reperfusion injury. The results suggest that taurepar is a promising antiarrhythmic drug with high antifibrillation activity.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/drug therapy , Myocardial Reperfusion Injury/drug therapy , Taurine/analogs & derivatives , Animals , Male , Myocardial Ischemia/drug therapy , Rats , Rats, Wistar , Taurine/therapeutic use
4.
Bull Exp Biol Med ; 157(6): 728-31, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25339588

ABSTRACT

Experiments on rats with acute myocardial ischemia accompanied by early postocclusive arrhythmias have shown normalizing, energy-stabilizing, and antiarrhythmic effects of uridine and uridine-5'-monophosphate. The drugs decreased lactate and restored reserves of glycogen and creatine phosphate depleted by ischemia. Uridine and uridine-5'-monophosphate significantly decreased the severity of ventricular arrhythmias. Both drugs reduced the incidence and duration of fibrillation. Uridine -5'-monophosphate demonstrated most pronounced antifibrillatory effectiveness. We hypothesize that the antiarrhythmic effect of the drugs is determined by their capacity to activate energy metabolism.


Subject(s)
Arrhythmias, Cardiac/drug therapy , Myocardial Ischemia/complications , Uridine Monophosphate/pharmacology , Uridine/pharmacology , Animals , Arrhythmias, Cardiac/etiology , Coronary Vessels/surgery , Energy Metabolism/drug effects , Energy Metabolism/physiology , Glycogen/blood , Lactic Acid/blood , Ligation , Male , Myocardial Ischemia/metabolism , Phosphocreatine/blood , Rats , Rats, Wistar
5.
Eksp Klin Farmakol ; 77(3): 33-6, 2014.
Article in Russian | MEDLINE | ID: mdl-24800524

ABSTRACT

The study was carried out on male Wistar rats with surgically ablated gonads. The rats with gonadectomy and intact rats received galantamine and/or testosterone over 10 days, after which the model arthritis was induced by injection of 200 ml of complete Freund's adjuvant. It was established that gonadectomy reduced arthritic reactions producing ulcer formation at a later time (21 days) as compared to control (rats with arthritis), where they are formed on the local stage of development (day 7). Testosterone replacement therapy completely blocks the development of ulcers on the paws. Galantamine suppresses the arthritic reaction more significantly, reducing paws and ankle-joint edema 1.5 and 1.3 times respectively (n = 12, p <0.05). The appearance of dopamine in the spleen during galantamine treatment may serve as a marker of protective action of the drug under hypoandrogenic conditions. Introduction of galantamine at high level of testosterone does not significantly influence on development of arthritic reaction, which is indicative of a marked imbalance between the hormonal and cholinergic systems and a possibility to modulate arthritic reaction with cholinergic drugs.


Subject(s)
Androgens/pharmacology , Arthritis, Experimental/drug therapy , Arthritis, Rheumatoid/drug therapy , Dopamine/metabolism , Galantamine/pharmacology , Parasympathomimetics/pharmacology , Testosterone/pharmacology , Animals , Arthritis, Experimental/metabolism , Arthritis, Experimental/pathology , Arthritis, Rheumatoid/metabolism , Arthritis, Rheumatoid/pathology , Edema/prevention & control , Hormone Replacement Therapy , Male , Prostatectomy , Rats , Rats, Wistar , Spleen/drug effects , Spleen/metabolism
6.
Bull Exp Biol Med ; 156(5): 612-4, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24770740

ABSTRACT

We studied the effects of dopamine D1/D2 receptor antagonists on the dynamics of acquisition and extinction of active avoidance responses and open field behavior in ovariectomized female rats. Dopamine D1 receptor antagonist SCH-23390 (0.1 mg/kg intraperitoneally) and dopamine D2 receptor antagonist sulpiride (10.0 mg/kg intraperitoneally) were administered chronically (14 days) either alone or in combination with a low dose of 17ß-estradiol (0.5 µg per rat subcutaneously) to females after ovariectomy. It was found that SCH-23390 in combination with a low dose of 17ß-estradiol completely restored impaired conditioning and retention of a conditioned avoidance response in ovariectomized animals. Simultaneous correction of behavioral patterns in the open field test was also observed in ovariectomized females receiving SCH-23390. Sulpiride injected alone or in combination with low dose of 17ß-estradiol did not correct conditioning and reproduction of active avoidance response in females with estrogen deficiency and did not significantly affect animal behavior. The results indicate positive effect of dopamine D1 receptor blockade on active learning under conditions of estrogen deficiency.


Subject(s)
Avoidance Learning/drug effects , Benzazepines/pharmacology , Dopamine Antagonists/pharmacology , Estradiol/administration & dosage , Sulpiride/pharmacology , Animals , Conditioning, Psychological/drug effects , Drug Evaluation, Preclinical , Estrogens/deficiency , Female , Motor Activity/drug effects , Ovariectomy , Rats, Wistar
7.
Eksp Klin Farmakol ; 76(5): 3-6, 2013.
Article in Russian | MEDLINE | ID: mdl-23901460

ABSTRACT

The aim of this work was to study the effect of stimulation or blockade of Na7-cholinoreceptors with a low dose of 17beta-estradiol on the passive avoidance performance and behavior in the open-field test in adult ovariectomized (OVX) female rats. Agonist of Na7-cholinoreceptors RJR-2403 (1.0 mg/kg, i.p.) or antagonist of Na7-cholinoreceptors mecamylamine (1.0 mg/kg, i.p.) treated chronically (14 days) alone and in a combination with low dose of 17beta-estradiol (0.5 microg/rat, s.c.) to OVX rats. Co-administration of RJR-2403 with low dose of 17P-estradiol completely restored impaired passive avoidance performance in OVX females. OVX rats treated with RJR-2403 and low dose of 17beta-estradiol demonstrated increased exploratory and grooming behavior in the open-field test. Both mecamylamine alone and in combination with low dose of 17beta-estradiol failed to influence the passive avoidance learning and failed to modify behavior in the open-field test in OVX rats. The results of the present study suggest positive effect of RJR-2403 in combination with low dose of 17beta-estradiol on passive avoidance learning at estrogen deficiency.


Subject(s)
Avoidance Learning/drug effects , Estradiol/pharmacology , Estrogens/pharmacology , Nicotine/analogs & derivatives , Ovariectomy , Animals , Dose-Response Relationship, Drug , Exploratory Behavior/drug effects , Female , Grooming/drug effects , Mecamylamine/pharmacology , Nicotine/pharmacology , Nicotinic Antagonists/pharmacology , Rats , Rats, Wistar , Receptors, Cholinergic/metabolism
8.
Eksp Klin Farmakol ; 76(12): 15-9, 2013.
Article in Russian | MEDLINE | ID: mdl-24605422

ABSTRACT

We have studied the effect of stimulation or blockade of the 5-HT(1A) receptors on the passive avoidance performance and open-field test behavior in gonadectomized (GDX) male rats of middle age treated with a low dose of testosterone propionate. of The 5-HT(1A) receptor agonist 8-OH-DPAT (0.05 mg/kg, s.c.) or 5-HT(1A) receptor antagonist NAN-190 (0.1 mg/kg, i.p.) were chronically (for 14 days) administered alone and in a combination with low dose of testosterone propionate (0.5 mg/kg, s.c.) in GDX rats of middle age (12 - 15 months). The co-administration of NAN-190 with low dose of testosterone propionate completely restored impaired passive avoidance performance in GDX males of middle age. Moreover, GDX rats of middle age treated with NAN-190 and low dose of testosterone propionate demonstrated increased exploratory and grooming behavior in the open-field test. Both 8-OH-DPAT alone and in combination with low dose of testosterone propionate markedly impaired passive avoidance learning and failed to modify behavior in the open-field test in GDX rats of middle age. The results of the present study are indicative of a positive effect of NAN-190 in combination with low dose of testosterone propionate on the passive avoidance learning at androgen deficiency in male rats of middle age.


Subject(s)
Androgens/deficiency , Avoidance Learning/drug effects , Piperazines/pharmacology , Serotonin Antagonists/pharmacology , Testosterone Propionate/pharmacology , Animals , Male , Rats , Rats, Wistar
9.
Bull Exp Biol Med ; 153(5): 644-6, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23113246

ABSTRACT

Experiments on rats have shown that preventive treatment with uridine stabilizes energy metabolism in the heart under conditions of 60-min left coronary artery occlusion. The preparation also prevented antioxidant system dysfunction and LPO hyperactivation. 5-Hydroxydecanoate, a selective blocker of mitochondrial ATP-dependent K(+)-channels, abolished the protective effect of uridine, which attested to the involvement of these channels into mechanisms of the cardioprotective effect of the preparation. The elimination of intravenously administered uridine from the blood of animals with acute ischemia was accelerated in comparison with that in intact animals, which could suggest the participation of this nucleoside in the processes of activation of intracellular anti-ischemic defense mechanisms.


Subject(s)
Coronary Occlusion/physiopathology , Energy Metabolism/drug effects , Myocardium/metabolism , Uridine/pharmacology , Adenosine Triphosphate/metabolism , Animals , Aryldialkylphosphatase/blood , Chromatography, High Pressure Liquid , Coronary Vessels/surgery , Glutathione/metabolism , Injections, Intravenous , Ligation , Lipid Peroxides/metabolism , Male , Phosphocreatine/metabolism , Rats , Rats, Wistar , Statistics, Nonparametric , Superoxide Dismutase/metabolism , Uridine/administration & dosage , Uridine/blood
11.
Bull Exp Biol Med ; 153(3): 378-84, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22866317

ABSTRACT

We studied the effect of silver ions on the status and metabolism of copper in rats receiving Ag-diet from the first day of life and for 6 months. The effect of silver ions on copper metabolism was assessed by body weight, relative weight of organs (body weight/organ weight), oxidase activity, content of immunoreactive ceruloplasmin and copper concentration in blood serum, by the expression of copper-transporting protein genes in the liver, and copper and silver distribution in liver and brain cells. Brain functions were evaluated by open-field behavior and passive avoidance conditioning. No acute deficiency of ceruloplasmin-associated copper was observed in rats receiving silver-enriched diet starting from the early postnatal period; copper metabolism in the liver did not change, psychoemotional state and memory corresponded to the control. However, Ag-diet almost 2-fold decelerated the growth of experimental rats. We hypothesize the existence of an unknown mechanism of copper delivery to organs in rats that is activated during the early ontogeny under conditions of ceruloplasmin-associated copper deficiency.


Subject(s)
Copper/metabolism , Silver Compounds/metabolism , Animals , Ceruloplasmin/metabolism , Liver/metabolism , Oxidation-Reduction , Rats
12.
Eksp Klin Farmakol ; 75(6): 14-22, 2012.
Article in Russian | MEDLINE | ID: mdl-22891436

ABSTRACT

This study was aimed at a comparative analysis of the effects of new amino acid derivatives of dopamine (IEM-2111, IEM-21122, IEM-2123, IEM-2126) on anxiety-like behavior in rats. The behavioral effects of the dopamine-like substances were evaluated under conditions of acute and chronic experiments. In acute experiment, a single dose of substances was administered 45 min prior to the behavioral testing of animals. In chronic experiment, the synthesized compounds were administered in a single daily dose for 14 days. Pharmacological analysis of the effect of drugs was performed in the following doses: 0.1, 1.0, and 10.0 mg/kg (i.p., introduction). Diazepam was used as a reference drug that was introduced in a dose of 1.0 mg/kg (i.p.). The anxiety-like state was determined using the elevated plus maze test, while the behavioral effects were evaluated in the open field test. It was found that IEM-2111, IEM-2122, and IEM-2123 exhibited anxiolytic action under condition of chronic administration, whereas IEM-2126 produced an anxiolytic effect only after acute administration. The introduction of left optical isomers of aromatic or heterocyclic radicals of amino acids into the molecule of 3,4-dimetoxyphenylethylamine results in a more pronounced anxiolytic effect upot chronic administration. The degree of action of the new amino acid derivatives of dopamine has a dose-dependent character, and the maximum effect is manifested at a dose of 1.0 mg/kg.


Subject(s)
Amino Acids/chemistry , Anti-Anxiety Agents/administration & dosage , Anxiety/drug therapy , Dopamine , Animals , Anxiety/physiopathology , Avoidance Learning/drug effects , Behavior, Animal/drug effects , Diazepam/administration & dosage , Dopamine/administration & dosage , Dopamine/analogs & derivatives , Dose-Response Relationship, Drug , Drug Administration Schedule , Emotions/drug effects , Male , Maze Learning/drug effects , Motor Activity/drug effects , Rats , Rats, Wistar , Stereoisomerism
13.
Eksp Klin Farmakol ; 75(4): 3-6, 2012.
Article in Russian | MEDLINE | ID: mdl-22702101

ABSTRACT

The involvement of D1-receptors in learning/memory processes during ovary cycle was assessed in the adult female rats. SKF-38393 (0,1 mg/kg, i.p.), D1-receptor agonist and SCH-23390 (0,1 mg/kg, i.p.), D1-receptor antagonist were injected chronically to adult female rats. Learning of these animals was assessed in different models: passive avoidance performance and Morris water maze. Chronic SKF-3839 administration to females resulted in the appearance of the passive avoidance performance in proestrous and estrous, as distinct from the control animals, but failed to change the dynamics of spatial learning in Morris water maze. Chronic SCH-23390 administration similarly impaired non-spatial and spatial learning in females during all phases of ovary cycle. The results of the study suggest modulating role of D1-receptors in learning/memory processes during ovary cycle in the adult female rats.


Subject(s)
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Avoidance Learning/drug effects , Dopamine Agonists/pharmacology , Estrus/drug effects , Proestrus/drug effects , Receptors, Dopamine D1/agonists , Animals , Avoidance Learning/physiology , Benzazepines/pharmacology , Female , Maze Learning/drug effects , Rats , Receptors, Dopamine D1/antagonists & inhibitors , Receptors, Dopamine D1/metabolism
15.
Eksp Klin Farmakol ; 75(1): 16-8, 2012.
Article in Russian | MEDLINE | ID: mdl-22442957

ABSTRACT

Hypolipidemic properties of a native trimethyl derivative of glycine, trimethylglycine (TMGl), were studied in hyperlipidemic rats and guinea pigs. The administration of TMGl to the hyperlipidemic rats and guinea pigs produced a pronounced hypolipidemic effect. A positive action of TMGl on the lipid profile of blood serum of the experimental animals was observed as manifested by a decrease in the level of cholesterol of low density lipoproteins (LDL) and an increase in the cholesterol level of high density lipoproteins (HDL).


Subject(s)
Anticholesteremic Agents/therapeutic use , Betaine/therapeutic use , Hyperlipidemias/drug therapy , Animals , Cholesterol/blood , Guinea Pigs , Hyperlipidemias/blood , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Liver/chemistry , Male , Mice , Rats
16.
Eksp Klin Farmakol ; 75(12): 7-10, 2012.
Article in Russian | MEDLINE | ID: mdl-23700659

ABSTRACT

The influence of D1/D2 types of dopaminergic receptors on the dynamics of acquisition and extinction of active avoidance performance and the behavior of ovariectomized female rats has been studied in the open field test. The DI-type dopaminergic receptor agonist SKF-38393 (0.1 mg/kg, i.p.) and D2-type dopaminergic receptor agonist quinperole (0.1 mg/kg, i.p.) were administered chronically (14 days) alone or in combination with low dose of 17beta-estradiol (0.5 microg/rat, s.c.) in animals after ovariectomy. It is established that quinperole in combination with low dose of 17beta-estradiol completely corrected impairments in the mechanisms of formation and retention of active avoidance performance in ovariectomized females. After quinperole treatment, this effect was also accompanied by the correction of behavior in the open field test. In contrast, the administration of SKF-38393 alone or in combination with low dose of 17beta-estradiol in female rats with estrogen deficiency neither corrected the formation and reproduction of active avoidance response of animals nor modified their behavior in the open field test. The results of the present study suggest important role of D2-type dopaminergic receptors in active avoidance performance development in animals with estrogen deficiency.


Subject(s)
Avoidance Learning/drug effects , Dopamine Agonists/pharmacology , Estradiol/pharmacology , Quinpirole/pharmacology , Receptors, Dopamine D2/agonists , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Animals , Behavior, Animal/drug effects , Drug Administration Schedule , Drug Synergism , Female , Injections, Intraperitoneal , Maze Learning/drug effects , Ovariectomy , Ovary/surgery , Rats , Receptors, Dopamine D1/agonists , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism
17.
Bull Exp Biol Med ; 149(5): 601-3, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21165397

ABSTRACT

Experiments on rats with myocardial ischemia modeled by occlusion of the left coronary artery aggravated by alimentary dislipoproteinemia showed that therapy with taurepar (50 mg/kg), a taurine derivative, decreased blood corticosterone concentration and increased the level of endogenous testosterone, which attests to normalization of the compensatory-adaptive and gonadotropic functions of the organism.


Subject(s)
Myocardial Ischemia/physiopathology , Taurine/analogs & derivatives , Testosterone/deficiency , Animals , Corticosterone/blood , Dietary Fats/administration & dosage , Dyslipidemias/drug therapy , Male , Myocardial Ischemia/complications , Rats , Taurine/therapeutic use , Testosterone/blood
18.
Bull Exp Biol Med ; 149(5): 598-600, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21165396

ABSTRACT

Model experiments on rats with endotoxic shock induced by intraperitoneal injection of LPS Salmonella Typhi strain ty-4441 (20 mg/kg) showed that crossing of the vagus nerve innervating the spleen increased HR, stimulated production of antibodies, and moderated serotonergic activity of splenocytes. Pharmacological correction of the shock with muscarinic receptor antagonist atropine and its combinations with anticholinesterase agent galantamine or muscarinic and nicotinic cholinoreceptor agonist choline alfoscerate 30 min before shock modeling moderated HR and normalized B cell functions and serotonin level in the spleen.


Subject(s)
Cholinergic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Spleen/innervation , Animals , Atropine/pharmacology , Denervation , Galantamine/pharmacology , Glycerylphosphorylcholine , Heart Rate/drug effects , Ipratropium/pharmacology , Lipopolysaccharides , Male , Nicotinic Agonists/pharmacology , Rats , Rats, Wistar , Salmonella typhi/immunology , Serotonin/metabolism , Shock, Septic/immunology
19.
Patol Fiziol Eksp Ter ; (3): 38-40, 2010.
Article in Russian | MEDLINE | ID: mdl-20853619

ABSTRACT

The results obtained on the model of starvation shows that nutritional dropsy led to the significant decrease of glucose, total cholesterol (TCh) and triglycerides (TC), as well as increase of non-estherified fatty acids (NEFA) in blood serum. In the rats with nutritional dropsy after treatment fed with standard diet enriched with soybean protein body weight returned to normal values as well as levels of Glucose, TCh and TC. However, concentration of NEFA remained increased. In the experimental group received additionally taurepar or taurhythman the level of NEFA decreased up to the normal one. It is necessary to mention that taurine derivatives did not change the biochemical parameters in blood of normal non-starved rats. We suppose that these new substances promote reduction of intensity of hyperlipidemic processes. It is known, that during starvation incomplete oxidation of fatty acids leads to acidosis with following destruction of mitochondria membraine. Finding property of taurine derivatives to decrease the concentration of non-estherified fatty acids points at their ability for restoration of tricarboxilic acid's cycle and prevention of accumulation of suboxidized molecules of NEFA and acidosis development.


Subject(s)
Blood Glucose/metabolism , Carbohydrate Metabolism/drug effects , Lipid Metabolism/drug effects , Starvation/blood , Taurine/analogs & derivatives , Animals , Disease Models, Animal , Food Deprivation , Male , Rats , Taurine/pharmacology
20.
Patol Fiziol Eksp Ter ; (2): 7-10, 2010.
Article in Russian | MEDLINE | ID: mdl-20804067

ABSTRACT

Development of anaphylactic shock initiated with the horse serum (anaphylactic index = 4.0 +/- 0.0 arbitrary units) leads to acute decrease in spleen concentration of serotonin (in shock--0.443 +/- 0.005; basal level--1.532 +/- 0.004 ng per mg of protein). Unlike of anaphylaxis, development of endotoxic shock in rats, caused by introduction of a sublethal dose (20 mg/kg) of lipopolysaccharide, results in acute increase in serotonin concentration (at a shock--56.588 +/- 0.006, basal level--5.465 +/- 0.005 ng per mg of protein) and marked tachycardia (+76 +/- 8, intact rats--+2 +/- 1 beats per min). Administration of atropine with galantamine leads to the most essential decrease of anaphylactic reaction (1.5 +/- 0.3 arbitrary units). Administration of choline alfoscerate (-16 +/- 3 beats per min) or galantamine (+9 +/- 2 beats per min) significantly reduces tachycardia. Data show, that inhibition of the central cholinergic mechanisms leads to increase and their excitation--to decrease in activity of the spleen serotonergic system. So, spleen concentration of serotonin is connected with a target of shock defeat (lungs or heart).


Subject(s)
Anaphylaxis/metabolism , Receptors, Cholinergic/metabolism , Receptors, Serotonin/metabolism , Shock, Septic/metabolism , Spleen/metabolism , Anaphylaxis/immunology , Anaphylaxis/prevention & control , Animals , Cholinesterase Inhibitors/administration & dosage , Cholinesterase Inhibitors/pharmacology , Cholinesterase Inhibitors/therapeutic use , Disease Models, Animal , Drug Interactions , Guinea Pigs , Male , Muscarinic Agonists/administration & dosage , Muscarinic Agonists/pharmacology , Muscarinic Agonists/therapeutic use , Muscarinic Antagonists/administration & dosage , Muscarinic Antagonists/pharmacology , Muscarinic Antagonists/therapeutic use , Nicotinic Agonists/administration & dosage , Nicotinic Agonists/pharmacology , Nicotinic Agonists/therapeutic use , Rats , Rats, Wistar , Serotonin/metabolism , Shock, Septic/immunology , Shock, Septic/prevention & control , Spleen/drug effects , Spleen/immunology
SELECTION OF CITATIONS
SEARCH DETAIL